The Wayback Machine - https://web.archive.org/web/20200704010152/https://academic.oup.com/jcem/pages/About
Skip to Main Content

About The Journal of Clinical Endocrinology & Metabolism

Editor-in-Chief, Associate Editors, and Editorial Board

Author Guidelines

Journal Facts for The Journal of Clinical Endocrinology & Metabolism

Patient Access

Obligations of Editors

Advertising

Meet the Incoming Editorial Team

Journal Facts for The Journal of Clinical Endocrinology & Metabolism

Impact Factor 2019: 5.399

Frequency of publication: Monthly

ISSN (print journal): 0021-972X

ISSN (online): 1945-7197

Discovery Resources: CABI, CINAHL, Clarivate, EBSCO, IFIS, OCLC, ProQuest/ExLibris, PubMed, TDNet, and Yewno

Contact

The Journal of Clinical Endocrinology & Metabolism

Endocrine Society

2055 L Street NW, Suite 600

Washington, DC  20036

Phone: 202-971-3669

publications@endocrine.org

Patient Access

  • Patients can request a copy of any article under access control. Please send the request to Member Services at info@endocrine.org. Please include the year, issue, page number, and title of the article. We also suggest that patients take advantage of the information from the Hormone Health Network.

Obligations of Editors

  • The Editor-in-Chief directs and supervises the policies of a journal and is responsible for maintaining its scientific and literary quality. The first obligation of an Editor-in-Chief and the journal’s Associate Editors is to make certain that all authors receive confidential, expert, critical, and unbiased reviews of their work in a timely fashion. The editors and members of the editor’s staff should not disclose any information about a manuscript submitted for review to anyone except the reviewers or authors or those working on their behalf.
  • An editor may not take part in the editorial management of any report of the editor’s own research because that involves conflict of interest. An editor must also avoid conflict of interest in the editorial management of reports of research closely related to the editor’s own research.
  • An editor may not use unpublished information of any kind from a submitted manuscript without written permission of the author.
  • If an editor is presented with convincing evidence that the main substance or conclusions of a report published in an editor’s journal is erroneous or determined to be the result of misconduct, the editor should facilitate prompt publication of a report pointing out the error and, if possible, correcting it. The report may be written by all the authors. For circumstances in which this is not possible, or there is disagreement, the Editor-in-Chief may consider the report written by some of the authors, academic or institutional sponsor, editor, or the Society.
  • The Endocrine Society appreciates the importance of assuring unbiased authorship of editorials, reviews, and other non-research features involving selection of evidence to be discussed and perspectives to be presented. Consequently, special care is taken in choosing authors for such articles to assure their views are balanced and unencumbered, and that the Society’s policies on disclosure of conflicts of interest are implemented.
  • The Endocrine Society journals will refrain from publishing articles addressing political issues that are outside of either research funding or health care delivery. See the Statement of Principle for more information.

Advertising

  • All Endocrine Society Journals contain advertisements but advertising is not allowed to influence editorial decisions. Readers will be able to readily distinguish between editorial material and advertising. The juxtaposition of advertisements promoting specific products and scientific articles discussing such products is, as far as possible, avoided.
  • The Endocrine Society and the editors do not provide unpublished advance information about journal content for forthcoming issues to agencies involved in soliciting advertisements or companies purchasing advertising space.
  • The appearance of any advertisement does not imply warranty, endorsement, or approval of the products or services or of their effectiveness, quality, or safety by the Endocrine Society.
  • The Society has the prerogative to reject any advertisement it deems inappropriate. It accepts advertisements only if the advertisers warrant that the advertisement does not contravene legal requirements on trade descriptions, medicines, race relations, or sex discrimination.
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close